Dominari (DOMH) 10-Q 14 Nov 18 2018 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2018	Nov. 13, 2018
Document And Entity Information
Entity Registrant Name	SPHERIX INC
Entity Central Index Key	12,239
Document Type	10-Q
Trading Symbol	SPEX
Document Period End Date	Sep. 30, 2018
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity's Reporting Status Current	Yes
Entity Small Business	true
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		8,542,530
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,018

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Current assets
Cash and cash equivalents	$ 109	$ 197
Marketable securities	3,409	3,998
Prepaid expenses and other assets	76	150
Total current assets	3,594	4,345
Property and equipment, net	1	3
Patent portfolios and patent rights, net	1,500	3,578
Investments at fair value	2,725	1,020
Deposit	26	26
Total assets	7,846	8,972
Current liabilities
Accounts payable and accrued expenses	68	56
Accrued salaries and benefits	578	695
Warrant liabilities	262	822
Payable to DatChat	348
Short-term deferred revenue		957
Short-term lease liabilities		48
Total current liabilities	1,256	2,578
Long-term deferred revenue		2,288
Total liabilities	1,256	4,866
Stockholders' equity
Common stock, $0.0001 par value, 100,000,000 shares authorized; 8,542,542 and 6,234,910 shares issued at September 30, 2018 and December 31, 2017, respectively; 8,542,530 and 6,234,898 shares outstanding at September 30, 2018 and December 31, 2017, respectively	1
Additional paid-in-capital	152,438	149,425
Treasury stock, at cost, 12 shares at September 30, 2018 and December 31, 2017	(264)	(264)
Accumulated deficit	(145,585)	(145,055)
Total stockholders' equity	6,590	4,106
Total liabilities and stockholders' equity	7,846	8,972
Series D Preferred Stock [Member]
Stockholders' equity
Preferred Stock
Series D-1 Convertible Preferred Stock [Member]
Stockholders' equity
Preferred Stock

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2018	Dec. 31, 2017
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized	100,000,000	100,000,000
Common stock, issued	8,542,542	6,234,910
Common stock, outstanding	8,542,530	6,234,898
Treasury stock	12	12
Series D Preferred Stock [Member]
Preferred stock, issued	4,725	4,725
Preferred stock, outstanding	4,725	4,725
liquidation preference (in dollars per share)	$ 0.0001	$ 0.0001
Series D-1 Convertible Preferred Stock [Member]
Preferred stock, issued	834	834
Preferred stock, outstanding	834	834
liquidation preference (in dollars per share)	$ 0.0001	$ 0.0001

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Income Statement [Abstract]
Revenues		$ 314		$ 952
Operating costs and expenses
Amortization of patent portfolio	346	346	1,027	1,027
Compensation and related expenses (including stock-based compensation)	206	488	903	1,371
Professional fees	210	280	1,202	815
Impairment of intangible assets	1,051		1,051
Rent	16	21	57	70
Depreciation expense	21	1	38	2
Acquisition costs	19		230
Other selling, general and administrative	82	137	282	372
Total operating expenses	1,951	1,273	4,790	3,657
Loss from operations	(1,951)	(959)	(4,790)	(2,705)
Other (expenses) income
Other (expenses) income, net	(35)	6	(225)	299
Change in fair value of investment		345	680	345
Change in fair value of warrant liabilities	95	1,067	560	(259)
Total other income	60	1,418	1,015	385
Net (loss) income	$ (1,891)	$ 459	$ (3,775)	$ (2,320)
Net income (loss) per share attributable to common stockholders, basic and diluted
Basic (in dollars per share)	$ (0.22)	$ 0.08	$ (0.48)	$ (0.44)
Diluted (in dollars per share)	$ (0.22)	$ 0.08	$ (0.48)	$ (0.44)
Weighted average number of common shares outstanding,
Basic (in shares)	8,542,530	5,998,920	7,894,936	5,304,201
Diluted (in shares)	8,542,530	6,009,042	7,894,936	5,304,201

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - 9 months ended Sep. 30, 2018 - USD ($) $ in Thousands	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-In Capital [Member]	Treasury Stock [Member]	Accumulated Deficit [Member]	Total
Beginning Balance at Dec. 31, 2017			$ 149,425	$ (264)	$ (145,055)	$ 4,106
Beginning Balance (in shares) at Dec. 31, 2017	6,234,898	5,559		12
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance common stock in equity raise, net of offering cost	$ 1		2,699			2,700
Issuance common stock in equity raise, net of offering cost (in shares)	2,222,222
Stock-based compensation			314			314
Stock-based compensation (in shares)	85,410
Cumulative effect of the changes related to adoption of					3,245	3,245
Net loss					(3,775)	(3,775)
Ending Balance at Sep. 30, 2018	$ 1		$ 152,438	$ (264)	$ (145,585)	$ 6,590
Ending Balance (in shares) at Sep. 30, 2018	8,542,530	5,559		12

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash flows from operating activities
Net loss	$ (3,775)	$ (2,320)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of patent portfolio	1,027	1,027
Change in fair value of investment	(680)	(345)
Change in fair value of warrant liabilities	(560)	259
Stock-based compensation	314	13
Depreciation expense	38	2
Realized loss on marketable securities	361	303
Unrealized loss (gain) on marketable securities	14	(262)
Impairment of intangible assets	1,051
Changes in assets and liabilities:
Prepaid expenses and other assets	74	93
Accounts payable and accrued expenses	12	(75)
Accrued salaries and benefits	(117)	(177)
Deferred revenue		(932)
Accrued lease liabilities	(48)	(133)
Net cash used in operating activities	(2,289)	(2,547)
Cash flows from investing activities
Purchase of marketable securities	(13,310)	(11,283)
Sale of marketable securities	13,524	12,533
Purchase of investments at fair value	(677)	(675)
Purchase of property and equipment	(36)
Net cash (used in) provided by investing activities	(499)	575
Cash flows from financing activities
Cash from issuance common stock, net of offering cost	2,700	2,095
Repurchase of restricted stock units to pay for employee withholding taxes		(24)
Net cash provided by financing activities	2,700	2,071
Net (decrease) increase in cash and cash equivalents	(88)	99
Cash and cash equivalents, beginning of period	197	134
Cash and cash equivalents, end of period	109	233
Cash paid for interest and taxes		195
Investment in DatChat	$ 348

Organization and Description of

Organization and Description of Business	9 Months Ended
	Sep. 30, 2018
Accounting Policies [Abstract]
Organization and Description of Business	Note 1. Organization and Description of Business Organization and Description of Business Spherix Incorporated (the “Company”) is an intellectual property company incorporated in the State of Delaware that owns patented and unpatented intellectual property. The Company was formed in 1967 as a scientific research company and for much of its history pursued drug development including through Phase III clinical studies which were discontinued. Through the Company’s acquisition of patents and patent applications developed by Nortel Networks Corporation from Rockstar Consortium US, LP (“Rockstar”) and Harris Corporation from North South Holdings Inc. (“North South”) in 2013, the Company has expanded its activities. The Company is a patent commercialization company focused on generating revenues from the monetization of intellectual property, or IP. Such monetization includes, but is not limited to, acquiring IP from patent holders in order to maximize the value of the patent holdings by conducting and managing a licensing campaign, or through the settlement and litigation of patents. We intend to generate revenues and related cash flows from the granting of intellectual property rights for the use of patented technologies that we own, that we manage for others, or that others manage on our behalf. To date, we have generated minimal revenues and no assurance can be provided that our business model will be successful. In addition to our patent monetization efforts, since the fourth quarter of 2017, we have been transitioning to focus our efforts as a technology development company. These efforts have focused on biotechnology research and blockchain technology research. The Company’s biotechnology research development includes investments in Hoth Therapeutics Inc. and the proposed merger with CBM BioPharma, Inc. (“CBM”). Hoth Therapeutics is a development stage biopharmaceutical company focused on proprietary therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema. To treat indications impacting more than 32 million Americans, Hoth is working to develop and commercialize the BioLexa™ Platform, a proprietary, patented, drug compound platform developed at the University of Cincinnati. The BioLexa™ Platform has achieved positive results at preclinical studies conducted at the University of Miami. In addition to Hoth, the Company is proposing a merger with CBM. In October 2018, the Company entered into an agreement and plan of merger, subject to shareholder approval, with CBM BioPharma, Inc. (“CBM”), a pharmaceutical company focusing on the development of cancer treatments, pursuant to which all shares of capital stock of CBM will be converted into the right to receive an aggregate of 15,000,000 shares of the Company’s common stock with CBM continuing as the surviving corporation in the merger. In the field of blockchain research, the Company previously entered into an agreement and plan of merger, subject to shareholder approval, with DatChat, Inc. (the “DatChat Merger”), a secure messaging application that utilizes blockchain technology. After further negotiations, the Company determined not to pursue a merger with DatChat and on August 8, 2018, entered into a Securities Purchase Agreement with DatChat pursuant to which the Company and DatChat agreed to terminate the DatChat Merger and the Company agreed to make a $1,000,000 strategic investment in DatChat which consisted of (a) a cash payment of $500,000, (b) the forgiveness of prior advances made to DatChat by the Company, and (c) an obligation of the Company to pay certain specific future compensation expenses of DatChat (amounts in clauses (b) and (c) not to exceed a maximum of $500,000 in the aggregate); in exchange for $1,000,000 of restricted shares of DatChat common stock which is equal to 4.37% of the issued and outstanding common stock of DatChat. Pursuant to the Securities Purchase Agreement, the Company applied a total of approximately $152,000 prior advances towards its investment in DatChat (“Prior Incurred Amount”), including $131,000 of compensation related costs and $21,000 professional fees. The Company also recorded approximately $348,000 compensation expenses payable to DatChat (“Payable to DatChat”) in addition to the $152,000 advances to reach the $500,000 maximum. The breakdown of investment at Datchat as September 30, 2018 are as follows ($ in thousands): DatChat Investment as of September 30, 2018 Cash Payment $ 500 Prior Incurred Amount Made to DatChat 152 Payable to DatChat 348 Total 1,000

Liquidity and Financial Conditi

Liquidity and Financial Condition	9 Months Ended
	Sep. 30, 2018
Liquidity And Financial Condition
Liquidity and Financial Condition	Note 2. Liquidity and Financial Condition The Company continues to incur ongoing administrative and other expenses, including public company expenses, in excess of corresponding (non-financing related) revenue. While the Company continues to implement its business strategy, it intends to finance its activities through: ● managing current cash and cash equivalents on hand from the Company’s past debt and equity offerings, ● seeking additional funds raised through the sale of additional securities in the future, ● seeking additional liquidity through credit facilities or other debt arrangements, and ● increasing revenue from its patent portfolios, license fees and new business ventures. Management believes the Company currently has sufficient funds to meet its operating requirements for at least the next twelve months. The Company’s ultimate success is dependent on its ability to obtain additional financing and generate sufficient cash flow to meet its obligations on a timely basis. The Company’s business will require significant amounts of capital to sustain operations and make the investments it needs to execute its longer-term business plan to support new technologies and help advance innovation. The Company’s working capital amounted to approximately $2.3 million at September 30, 2018. Absent generation of sufficient revenue from the execution of the Company’s long-term business plan, the Company will need to obtain additional debt or equity financing, especially if the Company experiences downturns in its business that are more severe or longer than anticipated, or if the Company experiences significant increases in expense levels resulting from being a publicly-traded company or operations. If the Company attempts to obtain additional debt or equity financing, the Company cannot assume that such financing will be available to the Company on favorable terms, or at all. Disputes regarding the assertion of patents and other intellectual property rights are highly complex and technical. The Company may be forced to litigate against others to enforce or defend its intellectual property rights or to determine the validity and scope of other parties’ proprietary rights. The defendants or other third parties involved in the lawsuits in which the Company is involved may allege defenses and/or file counterclaims or initiate inter-party reviews in an effort to avoid or limit liability and damages for patent infringement or cause the Company to incur additional costs as a strategy. If such efforts are successful, they may have an impact on the value of the patents and preclude the Company from deriving revenue from the patents. The patents could be declared invalid by a court or the United States Patent and Trademark Office, in whole or in part, or the costs of the Company can increase. Recent rulings also create an increased risk that if the Company is unsuccessful in litigation it could be responsible to pay the attorneys’ fees and other costs of defendants by lowering the standard for legal fee shifting sought by defendants in patent cases.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2018
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 3. Summary of Significant Accounting Policies Basis of Presentation and Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Nuta Technology Corp. (“Nuta”), Spherix Portfolio Acquisition II, Inc. (“SPAII”), Guidance IP, LLC (“Guidance”), Directional IP, LLC (“Directional”), Spherix Management Services, LLC (“SMS”), Spherix Delaware Merger Sub Inc. (“Merger Sub”), Spherix Merger Subsidiary, Inc (“SMSI”) and NNPT, LLC (“NNPT”). All significant intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“US GAAP”). This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include the recoverability and useful lives of long-lived assets, stock-based compensation, the valuation of derivative liabilities, the valuation of investments and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates, including the carrying amount of the intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions. Concentration of Cash The Company maintains cash balances at two financial institutions in checking accounts and money market accounts. The Company considers all highly liquid investments with original maturities of three months or less when purchased to be cash and cash equivalents. As of September 30, 2018 and December 31, 2017, the Company had $0.1 million and 0.2 million, respectively, in cash and cash equivalents. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash. Marketable Securities Marketable securities are classified as trading and are carried at fair value. The Company’s marketable securities consist of corporate bonds and highly liquid mutual funds which are valued at quoted market prices. The realized gain or loss, unrealized gain or loss, and dividend income related to marketable securities for the three and nine months ended September 30, 2018 and 2017 are as follows ($ in thousands): For the Three Months Ended September 30, For the Nine Months Ended September 30, 2018 2017 2018 2017 Realized gain (loss) $ (86 ) $ (174 ) $ (361 ) $ (303 ) Unrealized gain (loss) 3 124 (14 ) 262 Dividend income 44 18 121 72 $ (39 ) $ (32 ) $ (254 ) $ 31 The Company reinvested such dividend income into its marketable securities during the nine months ended September 30, 2018 and 2017. The fair values of such marketable securities held as of September 30, 2018 and December 31, 2017 were $3.4 million and $4.0 million, respectively. The marketable securities were classified as a Level 2 financial instrument at September 30, 2018 (see Note 8). Investment The Company records its investment in Hoth Therapeutics, Inc., a Nevada corporation (“Hoth”) at fair value. As of September 30, 2018, the fair value of this investment was $1,700,000. The Company also records its investment in TheBit Daily LLC, a Delaware limited liability company (“TheBit Daily”) at fair value. As of September 30, 2018, the fair value of this investment was $25,000. In addition, the Company made an $1,000,000 investment in DatChat on August 8, 2018. These investments were classified as a Level 3 financial instrument at September 30, 2018 (see Note 8). While the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The decision to elect the fair value option, which is irrevocable once elected, is determined on an instrument by instrument basis and applied to an entire instrument. The net gains or losses, if any, are recognized as an unrealized gain on investment in the Condensed Consolidated Statements of Operations. Net Loss per Share Basic loss per share is computed by dividing the net income or loss applicable to common shares by the weighted average number of common shares outstanding during the period. Net income (loss) attributable to common stockholders includes the effect of the deemed capital contribution on extinguishment of preferred stock and the deemed dividend related to the immediate accretion of beneficial conversion feature of convertible preferred stock. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options (using the treasury stock method) and the conversion of the Company’s convertible preferred stock and warrants (using the if-converted method). Diluted loss per share excludes the shares issuable upon the conversion of preferred stock and the exercise of stock options and warrants from the calculation of net loss per share if their effect would be anti-dilutive. Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share at September 30, 2018 and 2017 are as follows: As of September 30, 2018 2017 Convertible preferred stock 2,926 2,926 Warrants to purchase common stock 1,249,754 1,251,709 Options to purchase common stock 528,490 328,716 Total 1,781,170 1,583,351 Revenue Recognition The Company recognizes revenue when it is realized or realizable and earned. We consider revenue realized or realizable and earned when there is persuasive evidence of an arrangement when the services have been provided to the customer, the sales price is fixed or determinable and collectability is probable. Our material revenue stream is related to revenue generated from its settlement and licensing agreements. The appropriate recognition of revenue is determined as one performance obligation and revenue is recognized upon delivery of the final performance obligations, including the license for past and future use and the release. The Company recognizes revenue under ASC 606, Revenue from Contracts with Customers ● Step 1: Identify the contract with the customer ● Step 2: Identify the performance obligations in the contract ● Step 3: Determine the transaction price ● Step 4: Allocate the transaction price to the performance obligations in the contract ● Step 5: Recognize revenue when the company satisfies a performance obligation In order to identify the performance obligations in a contract with a customer, a company must assess the promised goods or services in the contract and identify each promised good or service that is distinct. A performance obligation meets ASC 606’s definition of a “distinct” good or service (or bundle of goods or services) if both of the following criteria are met: ● The customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (i.e., the good or service is capable of being distinct). ● The entity’s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (i.e., the promise to transfer the good or service is distinct within the context of the contract). If a good or service is not distinct, the good or service is combined with other promised goods or services until a bundle of goods or services is identified that is distinct. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer. The consideration promised in a contract with a customer may include fixed amounts, variable amounts, or both. When determining the transaction price, an entity must consider the effects of all of the following: ● Variable consideration ● Constraining estimates of variable consideration ● The existence of a significant financing component in the contract ● Noncash consideration ● Consideration payable to a customer Variable consideration is included in the transaction price only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. The transaction price is allocated to each performance obligation on a relative standalone selling price basis. The transaction price allocated to each performance obligation is recognized when that performance obligation is satisfied, at a point in time or over time as appropriate. As of September 30, 2018, there were no contract assets or liabilities associated with the Company’s settlement and licensing agreements. During the nine months ended September 30, 2018, the Company did not generate any revenue. Recently Issued Accounting Standards In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) Leases (Topic 840) In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features; II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception In June 2018, the FASB issued ASU 2018-07, Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders’ equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders’ equity presented in the balance sheet must be provided in a note or separate statement. The analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. This final rule is effective on November 5, 2018. The Company is evaluating the impact of this guidance on its condensed consolidated financial statements. In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820), – Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement,” which makes a number of changes meant to add, modify or remove certain disclosure requirements associated with the movement amongst or hierarchy associated with Level 1, Level 2 and Level 3 fair value measurements. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted upon issuance of the update. The Company does not expect the adoption of this guidance to have a material impact on its condensed consolidated Financial Statements. Recently Adopted Accounting Standards In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” (ASU 2014-09) as modified by ASU No. 2015-14, “Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date,” ASU 2016-08, “Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net),” ASU No. 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing,” and ASU No. 2016-12, “Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients.” The revenue recognition principle in ASU 2014-09 is that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, new and enhanced disclosures will be required. Companies may adopt the new standard either using the full retrospective approach, a modified retrospective approach with practical expedients, or a cumulative effect upon adoption approach. The Company adopted the new standard effective January 1, 2018, using the modified retrospective approach. The Company has determined that its licenses represent functional intellectual property under Topic 606. Therefore, revenue is recognized at the point in time when the customer has the right to use the intellectual property rather than over the license period. Accordingly, the Company’s deferred revenue related to its licenses was eliminated and accumulated deficit as of January 1, 2018 was decreased by approximately $3.2 million so that the Company will not recognize revenue on earnings statements in the future as to its license. In January 2016, the FASB issued ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities In May 2017, the Financial Accounting Standards Board (the FASB) issued ASU 2017-09, Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting

Investment in Hoth Therapeutics

Investment in Hoth Therapeutics, Inc	9 Months Ended
	Sep. 30, 2018
Investment In Hoth Therapeutics Inc
Investment in Hoth Therapeutics, Inc.	Note 4. Investment in Hoth Therapeutics, Inc. On June 30, 2017 (the “Closing Date”), the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Hoth Therapeutics, Inc., a Nevada corporation (“Hoth”), for the purchase of an aggregate of 6,800,000 shares of common stock, par value $0.0001 (the “Shares”), of Hoth, for a purchase price of $675,000. Company records this investment at fair value and recorded changes in fair value in the statement of operations (see Note 8).

Investment in TheBit Daily LLC

Investment in TheBit Daily LLC	9 Months Ended
	Sep. 30, 2018
Investment In Thebit Daily Llc
Investment in TheBit Daily LLC	Note 5. Investment in TheBit Daily LLC On March 23, 2018, Spherix Incorporated purchased 8.0% of the issued and outstanding limited liability company membership interests of TheBit Daily LLC, a development stage media and education platform focused on the blockchain and cryptocurrency space, for a subscription price of $25,000. The Company records this investment at fair value and changes in fair value are recorded (see Note 8).

Investment in DatChat, Inc.

Investment in DatChat, Inc.	9 Months Ended
	Sep. 30, 2018
Investment In Datchat Inc.
Investment in DatChat, Inc.	Note 6. Investment in DatChat, Inc. On August 8, 2018, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with DatChat. Under the Securities Purchase Agreement, the Company agreed to make a $1,000,000 strategic investment in DatChat. See Note 1 for further explanation. As described in Note 3 to these condensed consolidated financial statements, effective January 1, 2018, the Company adopted ASU 2016-01 concerning recognition and measurement of financial assets and financial liabilities. In adopting this new guidance, the Company has made an accounting policy election to adopt an adjusted cost method measurement alternative for its investment in DatChat. The Company records its investment at fair value and changes in fair value are recorded in the statement of operations (see Note 8).

Intangible Assets

Intangible Assets	9 Months Ended
	Sep. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Note 7. Intangible Assets Patent Portfolio and Patent Rights The Company’s intangible assets with finite lives consist of its patents and patent rights. For all periods presented, all of the Company’s identifiable intangible assets were subject to amortization. The carrying amounts related to acquired intangible assets as September 30, 2018 are as follows ($ in thousands): Net Carrying Amount Weighted average Patent Portfolios and Patent Rights at December 31, 2017, net $ 3,578 2.67 Amortization expenses (1,027 ) Impairment loss (1,051 ) Patent Portfolios and Patent Rights at September 30, 2018, net $ 1,500 1.00 The amortization expenses related to acquired intangible assets for the nine months ended September 30, 2018 and 2017 are as follows ($ in thousands): Amortization Expense for the Three Months Ended September 30, Amortization Expense for the Nine Months Ended September 30, Date Acquired and Description 2018 2017 2018 2017 7/24/13 - Rockstar patent portfolio $ 18 $ 18 $ 54 $ 53 9/10/13 - North South patent portfolio 5 5 16 16 12/31/13 - Rockstar patent portfolio 323 323 957 958 $ 346 $ 346 $ 1,027 $ 1,027 The Company reviews its patent portfolio for impairment as a single asset group whenever events or changes in circumstances indicate that the carrying value may not be recoverable. During the third quarter of 2018, the Company determined that certain events occurred that were indicators of a potential impairment. In accordance with ASC 360-10, the Company first estimated the future undiscounted cash flows anticipated to be generated by the patent portfolio based on the Company’s current usage and future plans for the patent portfolio over its remaining weighted average useful life. Given the short-term nature of the patents the undiscounted cash flows approximate discounted cash flows. The analysis concluded that the carrying amount of the patent portfolio was not recoverable at September 30, 2018. As a result, the Company performed an analysis to determine if the carrying value of the patent portfolio exceeded its fair value. As a result, the Company determined that the fair value of the patent portfolio at September 30, 2018 was $1.5 million. The Company recorded a $1.1 million impairment charge against its patent portfolio in the third quarter of 2018. The new cost basis of the patent portfolio of $1.5 million will be amortized over its weighted average remaining useful life of 1.00 years. The future amortization of these intangible assets was based on the adjusted carrying amount. Future amortization of all patents is as follows ($ in thousands): Rockstar North South Rockstar Portfolio Portfolio Portfolio Acquired Acquired Acquired Total 24-Jul-13 10-Sep-13 31-Dec-13 Amortization Nine Months Ended December 31, 2018 42 15 321 378 Year Ended December 31, 2019 129 42 951 1,122 Total $ 171 $ 57 $ 1,272 $ 1,500

Fair Value of Financial Assets

Fair Value of Financial Assets and Liabilities	9 Months Ended
	Sep. 30, 2018
Fair Value Disclosures [Abstract]
Fair Value of Financial Assets and Liabilities	Note 8. Fair Value of Financial Assets and Liabilities Financial instruments, including cash and cash equivalents, accounts and other receivables, accounts payable and accrued liabilities are carried at cost, which management believes approximates fair value due to the short-term nature of these instruments. The Company measures the fair value of financial assets and liabilities based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. The Company uses three levels of inputs that may be used to measure fair value: Level 1 - quoted prices in active markets for identical assets or liabilities Level 2 - quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 - inputs that are unobservable (for example, cash flow modeling inputs based on assumptions) The following table presents the Company’s assets and liabilities that are measured at fair value at September 30, 2018 and December 31, 2017 ($ in thousands): Fair value measured at September 30, 2018 Total carrying value at September 30, Quoted prices in active markets Significant other observable inputs Significant unobservable inputs 2018 (Level 1) (Level 2) (Level 3) Assets Marketable securities - mutual and exchange traded funds $ 3,409 $ — $ 3,409 $ — Investments at Hoth $ 1,700 $ — $ — $ 1,700 Investments at TheBit Daily $ 25 $ — $ — $ 25 Investments at DatChat $ 1,000 $ — $ — $ 1,000 Liabilities Fair value of warrant liabilities $ 262 $ — $ — $ 262 Fair value measured at December 31, 2017 Total carrying value at December Quoted prices in active markets Significant other observable inputs Significant unobservable inputs 31, 2017 (Level 1) (Level 2) (Level 3) Assets Marketable securities - mutual and exchange traded funds $ 3,998 $ — $ 3,998 $ — Investments at Hoth $ 1,020 $ — $ — $ 1,020 Liabilities Fair value of warrant liabilities $ 822 $ — $ — $ 822 There were no transfers between Level 1, 2 or 3 during the nine months ended September 30, 2018. Level 2 Valuation Techniques The fair values of Level 2 marketable securities are determined using one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly. Level 3 Valuation Techniques Level 3 financial liabilities consist of the warrant liabilities for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. A significant decrease in the volatility or a significant decrease in the Company’s stock price, in isolation, would result in a significantly lower fair value measurement. Changes in the values of the warrant liabilities are recorded in “change in fair value of warrant liabilities” in the Company’s consolidated statements of operations. The Series A and Series B warrants have been recorded at their fair value using the Black-Scholes valuation model, and will be recorded at their respective fair value at each subsequent balance sheet date. This model incorporates transaction details such as the Company’s stock price, contractual terms, maturity, risk free rates, as well as volatility. The warrants require, at the option of the holder, a net-cash settlement following certain fundamental transactions at the Company or require the issuance of registered shares upon exercise, do not expressly preclude an implied right to cash settlement and are therefore accounted for as derivative liabilities. A summary of quantitative information with respect to the valuation methodology and significant unobservable inputs used for the Company’s warrant liabilities that are categorized within Level 3 of the fair value hierarchy at the date of issuance and as of September 30, 2018 and December 31, 2017 is as follows: Date of valuation September 30, 2018 December 31, 2017 Risk-free interest rate 2.81% 1.98% Expected volatility 69.41% - 106.63% 100.00% - 132.21% Expected life (in years) 2.19-2.31 2.94 - 3.06 Expected dividend yield — — The risk-free interest rate was based on rates established by the Federal Reserve. For the July 2015 Warrants, the expected volatility in the Black-Scholes model is based on an expected volatility of 100% for both periods which represents the percentage required to be used when valuing the cash settlement feature as contractually stated in the form of warrant. The general expected volatility is based on standard deviation of the Company’s underlying stock price’s daily logarithmic returns. The expected life of the warrants was determined by the expiration date of the warrants. The expected dividend yield was based upon the fact that the Company has not historically paid dividends on its common stock and does not expect to pay dividends on its common stock in the future. The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities for the nine months ended September 30, 2018 and 2017 that are measured at fair value on a recurring basis ($ in thousands): Fair Value of Level 3 financial liabilities September 30, September 30, Beginning balance $ 822 $ 702 Fair value adjustment of warrant liabilities (560 ) 259 Ending balance $ 262 $ 961 The Company owns approximately 34% of common shares in Hoth as of September 30, 2018. The value of the Company’s investment in Hoth increased by approximately $0.7 million during the nine months ended September 30, 2018. The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial assets for the nine months ended September 30, 2018 and 2017 that are measured at fair value on a recurring basis: Fair Value of Level 3 investment September 30, September 30, 2018 2017 Beginning balance $ 1,020 $ — Purchase of investment in TheBit Daily LLC at fair value 25 — Purchase of investment in DatChat at fair value 1,000 Fair value of Hoth upon issuance — 675 Change in fair value of Hoth 680 345 Ending balance $ 2,725 $ 1,020 While the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The decision to elect the fair value option, which is irrevocable once elected, is determined on an instrument by instrument basis and applied to an entire instrument. A summary of quantitative information with respect to the valuation methodology and significant unobservable inputs used for the Company’s valuation in Hoth that are categorized within Level 3 of the fair value hierarchy at the date of issuance and as of September 30, 2018 and December 31, 2017 is as follows: Date of valuation September 30, 2018 December 31, 2017 Risk-free interest rate 2.24 % 1.39 % Expected volatility 75.00 % 75.00 % Expected life (in years) 1.00 1.00 The investment in Hoth Therapeutics was valued using a hybrid probability weighted expected return method, with scenarios including (1) Hoth continuing to operate as a private company through an estimated potential exit date, and (2) Hoth undergoing an IPO in the near future. The private-company scenario utilizes a reverse option pricing method (backsolve) based on the recent Series A transaction. Key inputs to the backsolve, in addition to the Series A price, include volatility (75.00%) and expected maturity (1.0 years). The IPO scenario is based on initial value indications proposed by investment bankers. The primary inputs, in addition to the pre-money value indications, include the estimated time to IPO (end of November) and a discount rate of 15%. The valuation conclusion is sensitive to the probability weightings assigned to each scenario. The weightings (1/3 IPO scenario, 2/3 private company scenario), were determined according to management expectations regarding exit opportunities, based on what was known or knowable as of September 30, 2018. The costs of its investment in the BitDaily and DatChat approximate fair value as there have been no significant changes to its investment since the date of purchase. Intangible Assets Measured at Fair Value on a Non-Recurring Basis using Level 3 Inputs The following tables presents the Company’s hierarchy for nonfinancial assets measured at fair value on a non-recurring basis (in thousands): Net carrying value at December 31, 2017 Impairment Charges - Assets Patent Portfolios, net $ 1,500 $ 1,051 Net carrying value at December 31, 2017 Impairment Charges - Assets Patent Portfolios, net $ 3,578 $ — The Company’s intangible assets are measured at fair value on a non-recurring basis using Level 3 inputs. See Note 7 for valuation techniques for patents.

Stockholders' Equity and Redeem

Stockholders' Equity and Redeemable Convertible Preferred Stock	9 Months Ended
	Sep. 30, 2018
Stockholders' Equity Note [Abstract]
Stockholders' Equity and Redeemable Convertible Preferred Stock	Note 9. Stockholders’ Equity and Redeemable Convertible Preferred Stock Common Stock On March 19, 2018, the Company closed a public offering of common stock for gross proceeds of approximately $3.0 million. The offering was a shelf takedown off of the Company’s registration statement on Form S-3 (File No. 333-222488) and was conducted pursuant to a placement agency agreement (the “Agreement”) between the Company and Laidlaw & Company (UK) Ltd., the sole placement agent, on a best-efforts basis with respect to the offering (the “Placement Agent”), that was entered into on March 14, 2018. The Company sold 2,222,222 shares of its common stock in the offering at a purchase price of $1.35 per share. Warrants A summary of warrant activity for the nine months ended September 30, 2018 is presented below: Weighted Average Remaining Contractual Weighted Average Life Warrants Exercise Price Total Intrinsic Value (in years) Outstanding as of December 31, 2017 1,249,754 $ 8.98 $ — 2.92 Outstanding as of September 30, 2018 1,249,754 $ 8.98 2.17 Exercisable as of September 30, 2018 1,249,754 $ 8.98 $ — 2.17 Stock Options On February 16, 2018, pursuant to and subject to the available number of shares reserved under the 2014 Plan, the Company issued an aggregate of 150,000 options to purchase common stock of the Company to three of its directors. The aggregate grant date fair value of these options was approximately $0.2 million. These stock options vested over six months. On May 3, 2018, a new director was granted options to purchase 50,000 shares of the Company’s common stock, at an exercise price of $1.04 per share, which options vested 50% at May 3, 2018 with the remaining 50% vesting at May 3, 2019. The aggregate grant date fair value of these options was approximately $46,000. These stock options vest over twelve months. A summary of option activity under the Company’s employee stock option plan for the nine months ended September 30, 2018 is presented below: Weighted Average Weighted Average Remaining Contractual Number of Shares Exercise Price Total Intrinsic Value Life (in years) Outstanding as of December 31, 2017 325,597 $ 78.20 $ 5,999 3.2 Employee options granted 200,000 1.39 — 9.4 Outstanding as of September 30, 2018 525,597 $ 48.97 $ — 5.1 Options vested and expected to vest 525,597 $ 48.97 $ — 5.1 Options vested and exercisable 500,597 $ 51.36 $ — 4.9 A summary of option activity under the Company’s non-employee stock option plan for the nine months ended September 30, 2018 is presented below: Weighted Average Weighted Average Remaining Contractual Number of Shares Exercise Price Total Intrinsic Value Life (in years) Outstanding as of December 31, 2017 2,893 $ 98.07 $ — 3.4 Outstanding as of September 30, 2018 2,893 $ 98.07 $ — 2.7 Options vested and expected to vest 2,893 $ 98.07 $ — 2.7 Options vested and exercisable 2,893 $ 98.07 $ — 2.7 Stock-based compensation associated with the amortization of stock option expense was approximately $28,000 and $2,000 for the three months ended September 30, 2018 and 2017, and was approximately $208,000 and $13,000 for the nine months ended September 30, 2018 and 2017, respectively. Restricted Stock Awards On February 16, 2018, the Company granted three of its directors 20,000 shares of restricted common stock each. The grant date fair value of each restricted stock award was approximately $27,000. These restricted stock awards vested immediately. On April 26, 2018, the Company issued 25,410 shares of its common stock to an employee for services pursuant to an employment agreement. The grant date fair value of this restricted stock award was approximately $27,000 (based upon the closing price of the Company’s common stock on April 26, 2018). This restricted stock award vested immediately. Stock-based Compensation Stock-based compensation for the nine months ended September 30, 2018 and 2017 was comprised of the following ($ in thousands): For the Three Months Ended September 30, For the Nine Months Ended September 30, 2018 2017 2018 2017 Employee restricted stock awards $ — $ — $ 106 $ — Employee stock option awards 28 2 208 13 Total compensation expense $ 28 $ 2 $ 314 $ 13 Unamortized stock-based compensation expense was approximately $14,000 at September 30, 2018.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2018
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 10. Commitments and Contingencies Legal Proceedings - Potential Gain Contingencies In the ordinary course of business, the Company actively pursues legal remedies to enforce its intellectual property rights and to stop unauthorized use of patented technology. From time to time, the Company may be involved in various claims and counterclaims and legal actions arising in the ordinary course of business. There were no pending material claims or legal matters as of the date of this report other than the following matters: International License Exchange of America, LLC Litigations Under our Monetization Agreement with Equitable, ILEA filed the patent infringement litigation below. ● On May 15, 2017, litigation against ADTRAN, Inc. case number 1:17-cv-00562-RGA, in the U.S. District Court for the District of Delaware, related to alleged infringement of the ‘999 patent and U.S. Patent Nos. 5,959,990; 6.970,461; 7,478,167; 7,274,704; and 7,277,533. On January 22, 2018, ILEA filed a notice of voluntary dismissal and the court terminated the case. Optic153 LLC Litigations Under our Monetization Agreement with Equitable, Optic153 LLC, an Equitable subsidiary, has filed the following litigations relating to patents acquired under the terms of settlement of one of our prior litigations: ● On March 15, 2018, litigation against Lumentum Operations LLC, Case No. 1:18-cv-00406-VAC-CJB, in the in the U.S. District Court for the District of Delaware, related to alleged infringement of U.S. Patent No. 6,587,261. Lumentum’s Answer is currently due on November 6, 2018. Counterclaims In the ordinary course of business, we, or with our wholly-owned subsidiaries or monetization partners, will initiate litigation against parties whom we believe have infringed on our intellectual property rights and technologies. The initiation of such litigation exposes us to potential counterclaims initiated by the defendants. Currently, there are no counterclaims pending against us. In the event such counterclaims are filed, we can provide no assurance that the outcome of these claims will not have a material adverse effect on our financial position and results from operations.

Recent Events

Recent Events	9 Months Ended
	Sep. 30, 2018
FairValueAdjustmentsForWarrantLiabilities
Recent Events	Note 11. Recent Events CBM Merger On October 10, 2018, the Company entered into an Agreement and Plan of Merger (the “ Merger Agreement Merger Sub Effective Time Stockholder Representative Pursuant to the Merger Agreement and subject to the terms and conditions set forth therein, at the closing of the transactions contemplated by the Merger Agreement, Merger Sub will merge with and into CBM (the “Merger”), with CBM continuing as the surviving corporation in the Merger. Subject to the terms and conditions set forth in the Merger Agreement, at the Effective Time: (i) all shares of capital stock of CBM (the “CBM Stock”) issued and outstanding immediately prior to the Effective Time will be converted into the right to receive the Stockholder Merger Consideration (as defined below) As consideration for the Merger, the Company shall deliver to the stockholders of CBM an aggregate of 15,000,000 shares of Company common stock (the “Stockholder Merger Consideration”), with each share of Company common stock valued at $1.10 per share. At or prior to the Closing, the Company, the Stockholder Representative, and a mutually agreeable escrow agent (the “Escrow Agent”), shall enter into an Escrow Agreement, effective as of the Effective Time, in form and substance reasonably satisfactory to the parties (the “Escrow Agreement”), pursuant to which the Company shall deposit with the Escrow Agent 1,500,000 shares from the Stockholder Merger Consideration otherwise deliverable to the stockholders of CBM who own beneficially and of record greater than 10% of the CBM common stock issued and outstanding immediately prior to the Closing (each a “Significant Company Stockholder”) (including any equity securities paid as dividends or distributions with respect to such shares or into which such shares are exchanged or converted, the “Escrow Shares”), to be held in a segregated escrow account (the “Escrow Account”) and disbursed by the Escrow Agent. Each stockholder of CBM Stockholder at the Effective Time (each, a “CBM Stockholder”) shall receive its pro rata share of the Stockholder Merger Consideration (less, in the case of each of the Significant Company Stockholders, its pro rata portion of the Escrow Shares held in the Escrow Account) based on the number of shares of CBM Stock owned by such CBM Stockholder as compared to the total number of shares of CBM Stock owned by all CBM Stockholders as of immediately prior to the Effective Time. The Escrow Shares shall serve as a security for, and a source of payment of, the indemnity rights of the Company indemnified parties. In the event that this Agreement is terminated by the Company pursuant to certain sections of the Agreement, then the Company may be required to deliver to CBM certificate(s) representing an aggregate of 400,000 shares of the Company’s Common Stock within two (2) business days of termination.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2018
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Nuta Technology Corp. (“Nuta”), Spherix Portfolio Acquisition II, Inc. (“SPXII”), Guidance IP, LLC (“Guidance”), Directional IP, LLC (“Directional”), Spherix Management Services, LLC (“SMS”), Spherix Delaware Merger Sub Inc. (“Merger Sub”) and NNPT, LLC (“NNPT”). All significant intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“US GAAP”). This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include the recoverability and useful lives of long-lived assets, stock-based compensation, the valuation of derivative liabilities, the valuation of investments and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates, including the carrying amount of the intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.
Concentration of Cash	Concentration of Cash The Company maintains cash balances at two financial institutions in checking accounts and money market accounts. The Company considers all highly liquid investments with original maturities of three months or less when purchased to be cash and cash equivalents. As of September 30, 2018 and December 31, 2017, the Company had $0.1 million and 0.2 million, respectively, in cash and cash equivalents. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash.
Marketable Securities	Marketable Securities Marketable securities are classified as trading and are carried at fair value. The Company’s marketable securities consist of corporate bonds and highly liquid mutual funds which are valued at quoted market prices. The realized gain or loss, unrealized gain or loss, and dividend income related to marketable securities for the three and nine months ended September 30, 2018 and 2017 are as follows ($ in thousands): For the Three Months Ended September 30, For the Nine Months Ended September 30, 2018 2017 2018 2017 Realized gain (loss) $ (86 ) $ (174 ) $ (361 ) $ (303 ) Unrealized gain (loss) 3 124 (14 ) 262 Dividend income 44 18 121 72 $ (39 ) $ (32 ) $ (254 ) $ 31 The Company reinvested such dividend income into its marketable securities during the nine months ended September 30, 2018 and 2017. The fair values of such marketable securities held as of September 30, 2018 and December 31, 2017 were $3.4 million and $4.0 million, respectively. The marketable securities were classified as a Level 2 financial instrument at September 30, 2018 (see Note 8).
Investment	Investment The Company records its investment in Hoth Therapeutics, Inc., a Nevada corporation (“Hoth”) at fair value. As of September 30, 2018, the fair value of this investment was $1,700,000. The Company also records its investment in TheBit Daily LLC, a Delaware limited liability company (“TheBit Daily”) at fair value. As of September 30, 2018, the fair value of this investment was $25,000. In addition, the Company made an $1,000,000 investment in DatChat on August 8, 2018. These investments were classified as a Level 3 financial instrument at September 30, 2018 (see Note 8). While the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The decision to elect the fair value option, which is irrevocable once elected, is determined on an instrument by instrument basis and applied to an entire instrument. The net gains or losses, if any, are recognized as an unrealized gain on investment in the Condensed Consolidated Statements of Operations.
Net Loss per Share	Net Loss per Share Basic loss per share is computed by dividing the net income or loss applicable to common shares by the weighted average number of common shares outstanding during the period. Net income (loss) attributable to common stockholders includes the effect of the deemed capital contribution on extinguishment of preferred stock and the deemed dividend related to the immediate accretion of beneficial conversion feature of convertible preferred stock. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options (using the treasury stock method) and the conversion of the Company’s convertible preferred stock and warrants (using the if-converted method). Diluted loss per share excludes the shares issuable upon the conversion of preferred stock and the exercise of stock options and warrants from the calculation of net loss per share if their effect would be anti-dilutive. Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share at September 30, 2018 and 2017 are as follows: As of September 30, 2018 2017 Convertible preferred stock 2,926 2,926 Warrants to purchase common stock 1,249,754 1,251,709 Options to purchase common stock 528,490 328,716 Total 1,781,170 1,583,351
Revenue Recognition	Revenue Recognition The Company recognizes revenue when it is realized or realizable and earned. We consider revenue realized or realizable and earned when there is persuasive evidence of an arrangement when the services have been provided to the customer, the sales price is fixed or determinable and collectability is probable. Our material revenue stream is related to revenue generated from its settlement and licensing agreements. The appropriate recognition of revenue is determined as one performance obligation and revenue is recognized upon delivery of the final performance obligations, including the license for past and future use and the release. The Company recognizes revenue under ASC 606, Revenue from Contracts with Customers ● Step 1: Identify the contract with the customer ● Step 2: Identify the performance obligations in the contract ● Step 3: Determine the transaction price ● Step 4: Allocate the transaction price to the performance obligations in the contract ● Step 5: Recognize revenue when the company satisfies a performance obligation In order to identify the performance obligations in a contract with a customer, a company must assess the promised goods or services in the contract and identify each promised good or service that is distinct. A performance obligation meets ASC 606’s definition of a “distinct” good or service (or bundle of goods or services) if both of the following criteria are met: ● The customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (i.e., the good or service is capable of being distinct). ● The entity’s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (i.e., the promise to transfer the good or service is distinct within the context of the contract). If a good or service is not distinct, the good or service is combined with other promised goods or services until a bundle of goods or services is identified that is distinct. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer. The consideration promised in a contract with a customer may include fixed amounts, variable amounts, or both. When determining the transaction price, an entity must consider the effects of all of the following: ● Variable consideration ● Constraining estimates of variable consideration ● The existence of a significant financing component in the contract ● Noncash consideration ● Consideration payable to a customer Variable consideration is included in the transaction price only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. The transaction price is allocated to each performance obligation on a relative standalone selling price basis. The transaction price allocated to each performance obligation is recognized when that performance obligation is satisfied, at a point in time or over time as appropriate. As of September 30, 2018, there were no contract assets or liabilities associated with the Company’s settlement and licensing agreements. During the nine months ended September 30, 2018, the Company did not generate any revenue.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Standards In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) Leases (Topic 840) In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features; II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception In June 2018, the FASB issued ASU 2018-07, Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders’ equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders’ equity presented in the balance sheet must be provided in a note or separate statement. The analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. This final rule is effective on November 5, 2018. The Company is evaluating the impact of this guidance on its condensed consolidated financial statements. In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820), – Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement,” which makes a number of changes meant to add, modify or remove certain disclosure requirements associated with the movement amongst or hierarchy associated with Level 1, Level 2 and Level 3 fair value measurements. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted upon issuance of the update. The Company does not expect the adoption of this guidance to have a material impact on its condensed consolidated Financial Statements.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Standards In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” (ASU 2014-09) as modified by ASU No. 2015-14, “Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date,” ASU 2016-08, “Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net),” ASU No. 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing,” and ASU No. 2016-12, “Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients.” The revenue recognition principle in ASU 2014-09 is that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, new and enhanced disclosures will be required. Companies may adopt the new standard either using the full retrospective approach, a modified retrospective approach with practical expedients, or a cumulative effect upon adoption approach. The Company adopted the new standard effective January 1, 2018, using the modified retrospective approach. The Company has determined that its licenses represent functional intellectual property under Topic 606. Therefore, revenue is recognized at the point in time when the customer has the right to use the intellectual property rather than over the license period. Accordingly, the Company’s deferred revenue related to its licenses was eliminated and accumulated deficit as of January 1, 2018 was decreased by approximately $3.2 million so that the Company will not recognize revenue on earnings statements in the future as to its license. In January 2016, the FASB issued ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities In May 2017, the Financial Accounting Standards Board (the FASB) issued ASU 2017-09, Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting

Organization and Description _2

Organization and Description of Business (Tables)	9 Months Ended
	Sep. 30, 2018
Accounting Policies [Abstract]
Schedule of breakdown of investment at datchat	The breakdown of investment at Datchat as September 30, 2018 are as follows ($ in thousands): DatChat Investment as of September 30, 2018 Cash Payment $ 500 Prior Incurred Amount Made to DatChat 152 Payable to DatChat 348 Total 1,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2018
Accounting Policies [Abstract]
Schedule of marketable securities	The realized gain or loss, unrealized gain or loss, and dividend income related to marketable securities for the three and nine months ended September 30, 2018 and 2017 are as follows ($ in thousands): For the Three Months Ended September 30, For the Nine Months Ended September 30, 2018 2017 2018 2017 Realized gain (loss) $ (86 ) $ (174 ) $ (361 ) $ (303 ) Unrealized gain (loss) 3 124 (14 ) 262 Dividend income 44 18 121 72 $ (39 ) $ (32 ) $ (254 ) $ 31
Schedule of potentially dilute loss per share	Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share at September 30, 2018 and 2017 are as follows: As of September 30, 2018 2017 Convertible preferred stock 2,926 2,926 Warrants to purchase common stock 1,249,754 1,251,709 Options to purchase common stock 528,490 328,716 Total 1,781,170 1,583,351

Intangible Assets (Tables)

Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of intangible assets	The carrying amounts related to acquired intangible assets as September 30, 2018 are as follows ($ in thousands): Net Carrying Amount Weighted average Patent Portfolios and Patent Rights at December 31, 2017, net $ 3,578 2.67 Amortization expenses (1,027 ) Impairment loss (1,051 ) Patent Portfolios and Patent Rights at September 30, 2018, net $ 1,500 1.00
Schedule of amortization to acquired intangible assets	The amortization expenses related to acquired intangible assets for the nine months ended September 30, 2018 and 2017 are as follows ($ in thousands): Amortization Expense for the Three Months Ended September 30, Amortization Expense for the Nine Months Ended September 30, Date Acquired and Description 2018 2017 2018 2017 7/24/13 - Rockstar patent portfolio $ 18 $ 18 $ 54 $ 53 9/10/13 - North South patent portfolio 5 5 16 16 12/31/13 - Rockstar patent portfolio 323 323 957 958 $ 346 $ 346 $ 1,027 $ 1,027
Schedule of future amortization of intangible assets	The future amortization of these intangible assets was based on the adjusted carrying amount. Future amortization of all patents is as follows ($ in thousands): Rockstar North South Rockstar Portfolio Portfolio Portfolio Acquired Acquired Acquired Total 24-Jul-13 10-Sep-13 31-Dec-13 Amortization Nine Months Ended December 31, 2018 42 15 321 378 Year Ended December 31, 2019 129 42 951 1,122 Total $ 171 $ 57 $ 1,272 $ 1,500

Fair Value of Financial Asset_2

Fair Value of Financial Assets and Liabilities (Tables)	9 Months Ended
	Sep. 30, 2018
Fair Value Disclosures [Abstract]
Schedule of fair value assets and liabilities	The following table presents the Company’s assets and liabilities that are measured at fair value at September 30, 2018 and December 31, 2017 ($ in thousands): Fair value measured at September 30, 2018 Total carrying value at September 30, Quoted prices in active markets Significant other observable inputs Significant unobservable inputs 2018 (Level 1) (Level 2) (Level 3) Assets Marketable securities - mutual and exchange traded funds $ 3,409 $ — $ 3,409 $ — Investments at Hoth $ 1,700 $ — $ — $ 1,700 Investments at TheBit Daily $ 25 $ — $ — $ 25 Investments at DatChat $ 1,000 $ — $ — $ 1,000 Liabilities Fair value of warrant liabilities $ 262 $ — $ — $ 262 Fair value measured at December 31, 2017 Total carrying value at December Quoted prices in active markets Significant other observable inputs Significant unobservable inputs 31, 2017 (Level 1) (Level 2) (Level 3) Assets Marketable securities - mutual and exchange traded funds $ 3,998 $ — $ 3,998 $ — Investments at Hoth $ 1,020 $ — $ — $ 1,020 Liabilities Fair value of warrant liabilities $ 822 $ — $ — $ 822
Schedule of fair value assumptions	A summary of quantitative information with respect to the valuation methodology and significant unobservable inputs used for the Company’s warrant liabilities that are categorized within Level 3 of the fair value hierarchy at the date of issuance and as of September 30, 2018 and December 31, 2017 is as follows: Date of valuation September 30, 2018 December 31, 2017 Risk-free interest rate 2.81% 1.98% Expected volatility 69.41% - 106.63% 100.00% - 132.21% Expected life (in years) 2.19-2.31 2.94 - 3.06 Expected dividend yield — — A summary of quantitative information with respect to the valuation methodology and significant unobservable inputs used for the Company’s valuation in Hoth that are categorized within Level 3 of the fair value hierarchy at the date of issuance and as of September 30, 2018 and December 31, 2017 is as follows: Date of valuation September 30, 2018 December 31, 2017 Risk-free interest rate 2.24 % 1.39 % Expected volatility 75.00 % 75.00 % Expected life (in years) 1.00 1.00
Schedule of fair value of the company's level 3 financial liabilities	The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities for the nine months ended September 30, 2018 and 2017 that are measured at fair value on a recurring basis ($ in thousands): Fair Value of Level 3 financial liabilities September 30, September 30, Beginning balance $ 822 $ 702 Fair value adjustment of warrant liabilities (560 ) 259 Ending balance $ 262 $ 961
Schedule of fair value of the Company's Level 3 financial assets	The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial assets for the nine months ended September 30, 2018 and 2017 that are measured at fair value on a recurring basis: Fair Value of Level 3 investment September 30, September 30, 2018 2017 Beginning balance $ 1,020 $ — Purchase of investment in TheBit Daily LLC at fair value 25 — Purchase of investment in DatChat at fair value 1,000 Fair value of Hoth upon issuance — 675 Change in fair value of Hoth 680 345 Ending balance $ 2,725 $ 1,020
Schedule of hierarchy for nonfinancial assets measured at fair value on a non-recurring basis	<font style="font: 10pt Times New Roman, Times, Serif">The following tables presents the Company’s hierarchy for nonfinancial assets measured at fair value on a non-recurring basis (in thousands):</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b> </b></font></td> <td style="padding-bottom: 1pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b> </b></font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>Net carrying value at December 31,  2017</b></font></td> <td style="padding-bottom: 1pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b> </b></font></td> <td style="padding-bottom: 1pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b> </b></font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>Impairment Charges -<br />Nine months ended <br />September 30, 2018</b></font></td> <td style="padding-bottom: 1pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b> </b></font></td></tr> <tr style="background-color: rgb(204,238,255); vertical-align: bottom"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Assets</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-left: 18px; width: 64%"><font style="font: 10pt Times New Roman, Times, Serif">Patent Portfolios, net</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; width: 15%"><font style="font: 10pt Times New Roman, Times, Serif">1,500</font></td> <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; width: 15%"><font style="font: 10pt Times New Roman, Times, Serif">1,051</font></td> <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b> </b></font></td> <td style="padding-bottom: 1pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b> </b></font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>Net carrying value at December 31,  2017</b></font></td> <td style="padding-bottom: 1pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b> </b></font></td> <td style="padding-bottom: 1pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b> </b></font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>Impairment Charges -<br />Nine months ended <br />September 30, 2017</b></font></td> <td style="padding-bottom: 1pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b> </b></font></td></tr> <tr style="background-color: rgb(204,238,255); vertical-align: bottom"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Assets</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td></tr> <tr style="background-color: white; vertical-align: bottom"> <td style="text-align: left; padding-left: 18px; width: 64%"><font style="font: 10pt Times New Roman, Times, Serif">Patent Portfolios, net</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; width: 15%"><font style="font: 10pt Times New Roman, Times, Serif">3,578</font></td> <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td> <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; width: 15%"><font style="font: 10pt Times New Roman, Times, Serif">—</font></td> <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif"> </font></td></tr> </table>" id="sjs-B8">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&lt;font style="font: 10pt Times New Roman, Times, Serif">The following tables presents the Company&#8217;s hierarchy for nonfinancial assets measured at fair value on a non-recurring basis (in thousands):&lt;/font>&lt;/p> &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/p> &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&lt;/p> &lt;table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"> &lt;tr style="vertical-align: bottom"> &lt;td style="text-align: justify">&lt;font style="font: 10pt Times New Roman, Times, Serif">&lt;b>&#160;&lt;/b>&lt;/font>&lt;/td> &lt;td style="padding-bottom: 1pt; font-weight: bold">&lt;font style="font: 10pt Times New Roman, Times, Serif">&lt;b>&#160;&lt;/b>&lt;/font>&lt;/td> &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">&lt;font style="font: 10pt Times New Roman, Times, Serif">&lt;b>Net carrying value at December 31,&#160;&#160;2017&lt;/b>&lt;/font>&lt;/td> &lt;td style="padding-bottom: 1pt; font-weight: bold">&lt;font style="font: 10pt Times New Roman, Times, Serif">&lt;b>&#160;&lt;/b>&lt;/font>&lt;/td> &lt;td style="padding-bottom: 1pt; font-weight: bold">&lt;font style="font: 10pt Times New Roman, Times, Serif">&lt;b>&#160;&lt;/b>&lt;/font>&lt;/td> &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">&lt;font style="font: 10pt Times New Roman, Times, Serif">&lt;b>Impairment Charges -&lt;br />Nine months ended &lt;br />September 30, 2018&lt;/b>&lt;/font>&lt;/td> &lt;td style="padding-bottom: 1pt; font-weight: bold">&lt;font style="font: 10pt Times New Roman, Times, Serif">&lt;b>&#160;&lt;/b>&lt;/font>&lt;/td>&lt;/tr> &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"> &lt;td style="text-align: justify">&lt;font style="font: 10pt Times New Roman, Times, Serif">Assets&lt;/font>&lt;/td> &lt;td>&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td style="text-align: left">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td style="text-align: right">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td style="text-align: left">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td>&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td style="text-align: left">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td style="text-align: right">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td style="text-align: left">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td>&lt;/tr> &lt;tr style="background-color: white; vertical-align: bottom"> &lt;td style="text-align: left; padding-left: 18px; width: 64%">&lt;font style="font: 10pt Times New Roman, Times, Serif">Patent Portfolios, net&lt;/font>&lt;/td> &lt;td style="width: 1%">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td style="text-align: left; width: 1%">&lt;font style="font: 10pt Times New Roman, Times, Serif">$&lt;/font>&lt;/td> &lt;td style="text-align: right; width: 15%">&lt;font style="font: 10pt Times New Roman, Times, Serif">1,500&lt;/font>&lt;/td> &lt;td style="text-align: left; width: 1%">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td style="width: 1%">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td style="text-align: left; width: 1%">&lt;font style="font: 10pt Times New Roman, Times, Serif">$&lt;/font>&lt;/td> &lt;td style="text-align: right; width: 15%">&lt;font style="font: 10pt Times New Roman, Times, Serif">1,051&lt;/font>&lt;/td> &lt;td style="text-align: left; width: 1%">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td>&lt;/tr> &lt;/table> &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/p> &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&lt;/p> &lt;table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"> &lt;tr style="vertical-align: bottom"> &lt;td style="text-align: justify">&lt;font style="font: 10pt Times New Roman, Times, Serif">&lt;b>&#160;&lt;/b>&lt;/font>&lt;/td> &lt;td style="padding-bottom: 1pt; font-weight: bold">&lt;font style="font: 10pt Times New Roman, Times, Serif">&lt;b>&#160;&lt;/b>&lt;/font>&lt;/td> &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">&lt;font style="font: 10pt Times New Roman, Times, Serif">&lt;b>Net carrying value at December 31,&#160;&#160;2017&lt;/b>&lt;/font>&lt;/td> &lt;td style="padding-bottom: 1pt; font-weight: bold">&lt;font style="font: 10pt Times New Roman, Times, Serif">&lt;b>&#160;&lt;/b>&lt;/font>&lt;/td> &lt;td style="padding-bottom: 1pt; font-weight: bold">&lt;font style="font: 10pt Times New Roman, Times, Serif">&lt;b>&#160;&lt;/b>&lt;/font>&lt;/td> &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">&lt;font style="font: 10pt Times New Roman, Times, Serif">&lt;b>Impairment Charges -&lt;br />Nine months ended &lt;br />September 30, 2017&lt;/b>&lt;/font>&lt;/td> &lt;td style="padding-bottom: 1pt; font-weight: bold">&lt;font style="font: 10pt Times New Roman, Times, Serif">&lt;b>&#160;&lt;/b>&lt;/font>&lt;/td>&lt;/tr> &lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"> &lt;td style="text-align: justify">&lt;font style="font: 10pt Times New Roman, Times, Serif">Assets&lt;/font>&lt;/td> &lt;td>&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td style="text-align: left">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td style="text-align: right">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td style="text-align: left">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td>&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td style="text-align: left">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td style="text-align: right">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td style="text-align: left">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td>&lt;/tr> &lt;tr style="background-color: white; vertical-align: bottom"> &lt;td style="text-align: left; padding-left: 18px; width: 64%">&lt;font style="font: 10pt Times New Roman, Times, Serif">Patent Portfolios, net&lt;/font>&lt;/td> &lt;td style="width: 1%">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td style="text-align: left; width: 1%">&lt;font style="font: 10pt Times New Roman, Times, Serif">$&lt;/font>&lt;/td> &lt;td style="text-align: right; width: 15%">&lt;font style="font: 10pt Times New Roman, Times, Serif">3,578&lt;/font>&lt;/td> &lt;td style="text-align: left; width: 1%">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td style="width: 1%">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td> &lt;td style="text-align: left; width: 1%">&lt;font style="font: 10pt Times New Roman, Times, Serif">$&lt;/font>&lt;/td> &lt;td style="text-align: right; width: 15%">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#8212;&lt;/font>&lt;/td> &lt;td style="text-align: left; width: 1%">&lt;font style="font: 10pt Times New Roman, Times, Serif">&#160;&lt;/font>&lt;/td>&lt;/tr> &lt;/table>

Stockholders' Equity and Rede_2

Stockholders' Equity and Redeemable Convertible Preferred Stock (Tables)	9 Months Ended
	Sep. 30, 2018
Stockholders' Equity Note [Abstract]
Schedule of warrant activity	A summary of warrant activity for the nine months ended September 30, 2018 is presented below: Weighted Average Remaining Contractual Weighted Average Life Warrants Exercise Price Total Intrinsic Value (in years) Outstanding as of December 31, 2017 1,249,754 $ 8.98 $ — 2.92 Outstanding as of September 30, 2018 1,249,754 $ 8.98 2.17 Exercisable as of September 30, 2018 1,249,754 $ 8.98 $ — 2.17
Schedule of option activity	A summary of option activity under the Company’s employee stock option plan for the nine months ended September 30, 2018 is presented below: Weighted Average Weighted Average Remaining Contractual Number of Shares Exercise Price Total Intrinsic Value Life (in years) Outstanding as of December 31, 2017 325,597 $ 78.20 $ 5,999 3.2 Employee options granted 200,000 1.39 — 9.4 Outstanding as of September 30, 2018 525,597 $ 48.97 $ — 5.1 Options vested and expected to vest 525,597 $ 48.97 $ — 5.1 Options vested and exercisable 500,597 $ 51.36 $ — 4.9 A summary of option activity under the Company’s non-employee stock option plan for the nine months ended September 30, 2018 is presented below: Weighted Average Weighted Average Remaining Contractual Number of Shares Exercise Price Total Intrinsic Value Life (in years) Outstanding as of December 31, 2017 2,893 $ 98.07 $ — 3.4 Outstanding as of September 30, 2018 2,893 $ 98.07 $ — 2.7 Options vested and expected to vest 2,893 $ 98.07 $ — 2.7 Options vested and exercisable 2,893 $ 98.07 $ — 2.7
Schedule of stock-based compensation	Stock-based compensation for the nine months ended September 30, 2018 and 2017 was comprised of the following ($ in thousands): For the Three Months Ended September 30, For the Nine Months Ended September 30, 2018 2017 2018 2017 Employee restricted stock awards $ — $ — $ 106 $ — Employee stock option awards 28 2 208 13 Total compensation expense $ 28 $ 2 $ 314 $ 13

Organization and Description _3

Organization and Description of Business (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Payable to DatChat	$ 348
Total	2,725	$ 1,020
DatChat, Inc [Member]
Cash Payment	500
Prior Incurred Amount Made to DatChat	152
Payable to DatChat	348
Total	$ 1,000

Organization and Description _4

Organization and Description of Business (Details Narrative) - USD ($) $ in Thousands	Aug. 08, 2018	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Compensation expenses		$ 28	$ 2	$ 314	$ 13
Professional fees		$ 210	$ 280	$ 1,202	$ 815
DatChat, Inc [Member] | Securities Purchase Agreement [Member]
Consideration transferred	$ 1,000,000
Proceeds from divestiture of businesses	500,000
Forgiveness of prior advances	152,000
Compensation related costs	131,000
Compensation expenses	131,000
Professional fees	$ 21,000
Description of equity interest issued	<font style="font: 10pt Times New Roman, Times, Serif"><a name="a_DV_C655"></a>in exchange for $1,000,000 of restricted shares of DatChat common stock which is equal to 4.37% of the issued and outstanding common stock of DatChat.</font></p>" id="sjs-B11">&lt;p style="font: 12pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&lt;font style="font: 10pt Times New Roman, Times, Serif">&lt;a name="a_DV_C655">&lt;/a>in exchange for $1,000,000 of restricted shares of DatChat common stock which is equal to 4.37% of the issued and outstanding common stock of DatChat.&lt;/font>&lt;/p>

Liquidity and Financial Condi_2

Liquidity and Financial Condition (Details Narrative) $ in Thousands	9 Months Ended
	Sep. 30, 2018USD ($)
Liquidity And Financial Condition
Working capital deficit	$ 2,300

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Accounting Policies [Abstract]
Realized losses marketable securities	$ (86)	$ (174)	$ 361	$ 303
Unrealized gains (losses) in marketable securities	3	124	(14)	262
Dividend income	44	18	121	72
Total	$ (39)	$ (32)	$ (254)	$ 31

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details 1) - shares	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Potentially dilute securities excluded from calculation	1,781,170	1,583,351
Convertible preferred stock [Member]
Potentially dilute securities excluded from calculation	2,926	2,926
Warrants to purchase common stock [Member]
Potentially dilute securities excluded from calculation	1,249,754	1,251,709
Options to purchase common stock [Member]
Potentially dilute securities excluded from calculation	528,490	328,716

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details Narrative) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017	Dec. 31, 2016
Cash and cash equivalents	$ 109	$ 233	$ 197	$ 134
Fair values of marketable securities	3,400		$ 4,000
Investment at fair value	677	$ 675
Hoth Therapeutics, Inc [Member]
Investment at fair value	1,700
TheBit Daily LLC [Member]
Investment at fair value	$ 25

Investment in Hoth Therapeuti_2

Investment in Hoth Therapeutics, Inc (Details Narrative) - Hoth Therapeutics, Inc [Member] - Securities Purchase Agreement [Member] $ / shares in Units, $ in Thousands	Jun. 30, 2017USD ($)$ / sharesshares
Share price (in dollars per share) | $ / shares	$ 0.0001
Number of common shares issued | shares	6,800,000
Purchase price | $	$ 675

Investment in TheBit Daily LLC

Investment in TheBit Daily LLC (Details Narrative) $ in Thousands	Mar. 23, 2018USD ($)
Cryptocurrency of subscription price	$ 25
TheBit Daily LLC [Member]
Limited liability of interests	8.00%

Investment in DatChat Inc (Deta

Investment in DatChat Inc (Details Narrative) - DatChat, Inc [Member] $ in Thousands	Aug. 08, 2018USD ($)
Maximum purchase amount for advances	$ 50,000
Securities Purchase Agreement [Member]
Consideration transferred	$ 1,000,000

Intangible Assets (Details)

Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Finite-lived Intangible Assets [Roll Forward]
Net carrying value Patent Portfolios, net			$ 3,578
Amortization expenses	$ (346)	$ (346)	(1,027)	$ (1,027)
Impairment Charges Patent Portfolios, net	$ 1,051		$ 1,051
Weighted average amortization period (years)			1 year
Patents [Member]
Finite-lived Intangible Assets [Roll Forward]
Net carrying value Patent Portfolios, net			$ 1,500	$ 3,578	$ 3,578
Amortization expenses			(1,027)
Impairment Charges Patent Portfolios, net			$ 1,051
Weighted average amortization period (years)			2 years 8 months 1 day		1 year

Intangible Assets (Details 1)

Intangible Assets (Details 1) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Amortization expenses	$ 346	$ 346	$ 1,027	$ 1,027
7/24/13 - Rockstar Patent Portfolio Acquired [Member]
Amortization expenses	18	18	54	53
9/10/13 - North South patent portfolio Acquired [Member]
Amortization expenses	5	5	16	16
12/31/13 - Rockstar Patent Portfolio Acquired [Member]
Amortization expenses	$ 323	$ 323	$ 957	$ 958

Intangible Assets (Details 2)

Intangible Assets (Details 2) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Nine Months Ended December 31, 2018	$ 378
Year Ended December 31, 2019	1,122
Total	1,500	$ 3,578
7/24/13 - Rockstar Patent Portfolio Acquired [Member]
Nine Months Ended December 31, 2018	42
Year Ended December 31, 2019	129
Total	171
9/10/13 - North South patent portfolio Acquired [Member]
Nine Months Ended December 31, 2018	15
Year Ended December 31, 2019	42
Total	57
12/31/13 - Rockstar Patent Portfolio Acquired [Member]
Nine Months Ended December 31, 2018	321
Year Ended December 31, 2019	951
Total	$ 1,272

Intangible Assets (Details Narr

Intangible Assets (Details Narrative) $ in Thousands	9 Months Ended
	Sep. 30, 2018USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Fair value of the petant portfolio	$ 1,500
Impairment charges	1,100
Revised cost of the patent	$ 1,500
Weighted average amortization period (years)	1 year

Fair Value of Financial Asset_3

Fair Value of Financial Assets and Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017	Sep. 30, 2017	Dec. 31, 2016
Assets
Marketable securities - mutual and exchange traded funds	$ 3,409	$ 3,998
Investments at fair value	2,725	1,020
Liabilities
Fair value of warrant liabilities	262	822
Quoted prices in active markets (Level 1) [Member]
Assets
Marketable securities - mutual and exchange traded funds
Investments at fair value
Liabilities
Fair value of warrant liabilities
Significant other observable inputs (Level 2) [Member]
Assets
Marketable securities - mutual and exchange traded funds	3,409	3,998
Investments at fair value
Liabilities
Fair value of warrant liabilities
Significant unobservable inputs (Level 3) [Member]
Assets
Marketable securities - mutual and exchange traded funds
Investments at fair value	2,725	1,020	$ 1,020
Liabilities
Fair value of warrant liabilities	262	822
Hoth [Member]
Assets
Investments at fair value	1,700		$ 1,020
Hoth [Member] | Significant unobservable inputs (Level 3) [Member]
Assets
Investments at fair value	1,700	$ 1,020
TheBit Daily LLC [Member]
Assets
Investments at fair value	25
TheBit Daily LLC [Member] | Significant unobservable inputs (Level 3) [Member]
Assets
Investments at fair value	25
DatChat [Member]
Assets
Investments at fair value	1,000
DatChat [Member] | Significant unobservable inputs (Level 3) [Member]
Assets
Investments at fair value	$ 1,000

Fair Value of Financial Asset_4

Fair Value of Financial Assets and Liabilities (Details 1)	9 Months Ended	12 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Risk Free Interest Rate [Member]
Measurement input	0.0224	0.0139
Price Volatility [Member]
Measurement input	0.7500	0.7500
Price Volatility [Member] | Minimum [Member]
Measurement input	0.6941	1
Price Volatility [Member] | Maximum [Member]
Measurement input	1.0663	1.3221
Expected Term [Member]
Expected life (in years)	1 year	1 year
Expected Term [Member] | Minimum [Member]
Expected life (in years)	2 years 2 months 8 days	2 years 11 months 8 days
Expected Term [Member] | Maximum [Member]
Expected life (in years)	2 years 3 months 21 days	3 years 22 days
Expected Dividend Rate [Member]
Measurement input

Fair Value of Financial Asset_5

Fair Value of Financial Assets and Liabilities (Details 2) - Significant unobservable inputs (Level 3) [Member] - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 822	$ 702
Fair value adjustment of warrant liabilities	(560)	259
Ending balance	$ 262	$ 961

Fair Value of Financial Asset_6

Fair Value of Financial Assets and Liabilities (Details 3) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Beginning balance			$ 1,020
Purchase of investment in TheBit Daily LLC at fair value		$ 345	680	$ 345
Ending balance	2,725		2,725
Significant unobservable inputs (Level 3) [Member]
Beginning balance			1,020
Purchase of investment in TheBit Daily LLC at fair value			25
Purchase of investment in DatChat at fair value			1,000
Fair value of Hoth upon issuance				675
Change in fair value of Hoth			680	345
Ending balance	$ 2,725	$ 1,020	$ 2,725	$ 1,020

Fair Value of Financial Asset_7

Fair Value of Financial Assets and Liabilities (Details 4)	9 Months Ended	12 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Risk Free Interest Rate [Member]
Measurement input	0.0224	0.0139
Expected volatility [Member]
Measurement input	0.7500	0.7500
Expected Term [Member]
Expected life (in years)	1 year	1 year

Fair Value of Financial Asset_8

Fair Value of Financial Assets and Liabilities (Details 5) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Finite-lived Intangible Assets [Roll Forward]
Net carrying value Patent Portfolios, net			$ 3,578
Amortization expenses	$ (346)	$ (346)	(1,027)	$ (1,027)
Patent Portfolios, net impairment charges	$ 1,051		1,051
Patents [Member]
Finite-lived Intangible Assets [Roll Forward]
Net carrying value Patent Portfolios, net			1,500	$ 3,578	$ 3,578
Amortization expenses			(1,027)
Patent Portfolios, net impairment charges			$ 1,051

Stockholders' Equity and Rede_3

Stockholders' Equity and Redeemable Convertible Preferred Stock (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Warrants [Abstract]
Warrants, Outstanding at beginning	$ 1,249,754
Warrants, Outstanding at ending		$ 1,249,754
Warrants, Exercisable	$ 1,249,754
Warrants, Weighted Average Exercise Price [Abstract]
Warrants. Weighted average exercise price at beginning	$ 8.98
Warrants, Weighted average exercise price at ending		$ 8.98
Warrants, Exercisable of weighted average exercise price	$ 8.98
Warrants, Total Intrinsic Value [Abstract]
Warrants, Intrinsic value at beginning
Warrants, Intrinsic value at ending
Warrants, Intrinsic value exercisable
Warrants, Weighted Average Remaining Contractual Life [Abstract]
Warrants, Weighted average remaining contractual life at beginning	2 years 2 months 1 day	2 years 11 months 1 day
Warrants, Weighted average remaining contractual life at ending	2 years 2 months 1 day	2 years 11 months 1 day
Warrants, Weighted average remaining exercisable	2 years 2 months 1 day

Stockholders' Equity and Rede_4

Stockholders' Equity and Redeemable Convertible Preferred Stock (Details 1) - Stock Option [Member] $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2018USD ($)$ / sharesshares
Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of Shares [Roll Forward]
Outstanding at beginning | shares	325,597
Employee options granted | shares	200,000
Outstanding at ending | shares	525,597
Options vested and expected to vest | shares	525,597
Options vested and exercisable | shares	500,597
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Outstanding at beginning | $ / shares	$ 78.20
Employee options granted | $ / shares	1.39
Outstanding at ending | $ / shares	48.97
Options vested and expected to vest | $ / shares	48.97
Options vested and exercisable | $ / shares	$ 51.36
Share-based Compensation Arrangement by Share-based Payment Award, Options, Total Intrinsic Value [Roll Forward]
Outstanding at beginning | $	$ 5,999
Employee options granted | $
Employee options expired | $
Outstanding at ending | $
Options vested and expected to vest | $
Options vested and exercisable | $
Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Life [Roll Forward]
Outstanding at beginning	3 years 2 months 12 days
Employee options granted	9 years 4 months 24 days
Outstanding at ending	5 years 1 month 6 days
Options vested and expected to vest	5 years 1 month 6 days
Options vested and exercisable	4 years 10 months 24 days
Non-Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of Shares [Roll Forward]
Outstanding at beginning | shares	2,893
Outstanding at ending | shares	2,893
Options vested and expected to vest | shares	2,893
Options vested and exercisable | shares	2,893
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Outstanding at beginning | $ / shares	$ 98.07
Outstanding at ending | $ / shares	98.07
Options vested and expected to vest | $ / shares	98.07
Options vested and exercisable | $ / shares	$ 98.07
Share-based Compensation Arrangement by Share-based Payment Award, Options, Total Intrinsic Value [Roll Forward]
Outstanding at beginning | $
Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Life [Roll Forward]
Outstanding at beginning	3 years 4 months 24 days
Outstanding at ending	2 years 8 months 4 days
Options vested and expected to vest	2 years 8 months 4 days
Options vested and exercisable	2 years 8 months 4 days

Stockholders' Equity and Rede_5

Stockholders' Equity and Redeemable Convertible Preferred Stock (Details 2) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Total compensation expense	$ 28	$ 2	$ 314	$ 13
Stock Option [Member]
Total compensation expense	28	2	106
Restricted Stock Units [Member]
Total compensation expense			$ 208	$ 13

Stockholders' Equity and Rede_6

Stockholders' Equity and Redeemable Convertible Preferred Stock (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands	May 03, 2018	Apr. 26, 2018	Mar. 19, 2018	Feb. 16, 2018	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Allocated stock based compensation					$ 28	$ 2	$ 208	$ 13
Unamortized stock-based compensation expense							14
Three Directors [Member] | Restricted Stock Units [Member]
Fair value of stock options granted				$ 27
Number of options granted				20,000
Director [Member]
Shares price (in dollars per share)	$ 1.04
Fair value of stock options granted	$ 46,000
Number of options granted	50,000
Employee [Member] | Employment Agreement [Member]
Number of shares issued for services		25,410
Fair value of shares issued for services		$ 27,000
2014 Equity Incentive Plan [Member] | Three Directors [Member]
Fair value of stock options granted							$ 200
Number of options granted							150,000
IPO [Member]
Number of shares issued			2,222,222
Net proceeds form offering			$ 3,000
Shares price (in dollars per share)			$ 1.35

Recent Events (Details Narrativ

Recent Events (Details Narrative) - USD ($) $ in Thousands	Oct. 10, 2018	Sep. 30, 2018	Dec. 31, 2017
Common stock share issued		8,542,542	6,234,910
Common stock value (in dollars per share)		$ 1
CBM Biopharma Inc [Member] | Subsequent Event [Member]
Common stock share issued	15,000,000
Common stock value (in dollars per share)	$ 1
CBM Biopharma Inc [Member] | Subsequent Event [Member] | Escrow Agreement [Member]
Description of merger consideration	<font style="font: 10pt Times New Roman, Times, Serif">the Company shall deposit with the Escrow Agent 1,500,000 shares from the Stockholder Merger Consideration otherwise deliverable to the stockholders of CBM who own beneficially and of record greater than 10% of the CBM common stock issued and outstanding immediately prior to the Closing.</font></p>" id="sjs-B8">&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0">&lt;font style="font: 10pt Times New Roman, Times, Serif">the Company shall deposit with the Escrow Agent 1,500,000 shares from the Stockholder Merger Consideration otherwise deliverable to the stockholders of CBM who own beneficially and of record greater than 10% of the CBM common stock issued and outstanding immediately prior to the Closing.&lt;/font>&lt;/p>